Target type: molecularfunction
Binding to tetrahydrofolyl-poly(glutamate) polymer. [GO_REF:0000067, GOC:BHF, GOC:hal, GOC:TermGenie, PMID:24863754]
Tetrahydrofolyl-poly(glutamate) polymer binding describes the interaction of proteins with the polyglutamated forms of tetrahydrofolate (THF). THF is a crucial cofactor in various metabolic pathways, including nucleotide biosynthesis, amino acid metabolism, and the synthesis of DNA and RNA. Polyglutamylation of THF, the addition of multiple glutamate residues to the molecule, enhances its affinity for specific enzymes involved in these pathways.
The molecular function of tetrahydrofolyl-poly(glutamate) polymer binding involves the following steps:
1. **Recognition and Binding:** Proteins with tetrahydrofolyl-poly(glutamate) polymer binding activity possess specific binding sites that recognize and interact with the polyglutamate chain of THF. The number of glutamate residues in the polyglutamate chain can vary depending on the enzyme and cellular location.
2. **Conformation Change:** Upon binding of the polyglutamated THF, the protein may undergo a conformational change, bringing the active site closer to the substrate. This conformational change is crucial for the efficient catalysis of the enzymatic reaction.
3. **Substrate Delivery:** The polyglutamate chain acts as a tether, keeping the THF molecule in close proximity to the active site of the enzyme, ensuring efficient substrate delivery and preventing diffusion away from the enzyme.
4. **Regulation of Enzyme Activity:** The length of the polyglutamate chain can influence the activity of the enzyme. In some cases, longer polyglutamate chains can increase the affinity of the enzyme for the substrate, leading to enhanced catalytic activity.
5. **Subcellular Localization:** Polyglutamylation can also regulate the subcellular localization of enzymes, directing them to specific cellular compartments where their activity is required.
The specific interactions between the polyglutamate chain and the protein binding site vary depending on the protein and the cellular context. However, these interactions generally involve hydrogen bonds, ionic interactions, and hydrophobic interactions.
Overall, tetrahydrofolyl-poly(glutamate) polymer binding is a crucial process for the efficient and regulated activity of a wide range of metabolic enzymes. This process ensures the proper functioning of essential metabolic pathways, including nucleotide biosynthesis, amino acid metabolism, and DNA and RNA synthesis.'
"
Protein | Definition | Taxonomy |
---|---|---|
Glutamate carboxypeptidase 2 | A glutamate carboxypeptidase 2 that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q04609] | Homo sapiens (human) |
Compound | Definition | Classes | Roles |
---|---|---|---|
glutamic acid | glutamic acid : An alpha-amino acid that is glutaric acid bearing a single amino substituent at position 2. Glutamic Acid: A non-essential amino acid naturally occurring in the L-form. Glutamic acid is the most common excitatory neurotransmitter in the CENTRAL NERVOUS SYSTEM. | glutamic acid; glutamine family amino acid; L-alpha-amino acid; proteinogenic amino acid | Escherichia coli metabolite; ferroptosis inducer; micronutrient; mouse metabolite; neurotransmitter; nutraceutical |
quisqualic acid | Quisqualic Acid: An agonist at two subsets of excitatory amino acid receptors, ionotropic receptors that directly control membrane channels and metabotropic receptors that indirectly mediate calcium mobilization from intracellular stores. The compound is obtained from the seeds and fruit of Quisqualis chinensis. | non-proteinogenic alpha-amino acid | |
plasmenylserine | O-phospho-L-serine : The L-enantiomer of O-phosphoserine. O-phosphoserine : A serine derivative that is serine substituted at the oxygen atom by a phosphono group. plasmenylserine: RN given refers to (L)-isomer | O-phosphoserine | EC 1.4.7.1 [glutamate synthase (ferredoxin)] inhibitor; EC 2.5.1.49 (O-acetylhomoserine aminocarboxypropyltransferase) inhibitor; EC 4.3.1.10 (serine-sulfate ammonia-lyase) inhibitor; Escherichia coli metabolite; human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite |
alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid | |||
serine o-sulfate | L-serine O-sulfate : A non-proteinogenic L-alpha-amino acid that is the O-sulfo derivative of L-serine. serine O-sulfate: RN given refers to (L)-isomer | L-serine derivative; non-proteinogenic L-alpha-amino acid; O-sulfoamino acid | |
isospaglumic acid | Ac-Asp-Glu : A dipeptide composed of N-acetyl-L-aspartic acid and L-glutamic acid joined by a peptide linkage. isospaglumic acid: mediator in the sensitivity of animals to hyperbaric oxygenation; Naaxia is the tradename; apparently can have both a neuroprotective and a neurotoxic effect | dipeptide | human metabolite |
sq 14,603 | 2-benzyl-3-mercaptopropanoic acid: structure; carboxypeptidase inhibitor | ||
willardiine | 3-(uracil-1-yl)-L-alanine : The 3-(uracil-1-yl) derivative of L-alanine. willardiine: isolated from seeds of Acacia willariana; structure | amino acid zwitterion; L-alanine derivative; non-proteinogenic L-alpha-amino acid | |
gamma-glutamyl hydroxamate | glutamine hydroxamate : A hydroxamic acid that is L-glutamine hydroxylated at N-5. | amino acid zwitterion; glutamic acid derivative; hydroxamic acid | |
phenobarbital sodium | 2-(phosphonomethyl)pentanedioic acid: an N-acetylated alpha-linked acidic dipeptidase (NAALADase) antagonist | ||
gpi 5693 | 2-(3-mercaptopropyl)pentanedioic acid: inhibits glutamate carboxypeptidase II; structure in first source | ||
zj43 | ZJ43: N-acetylaspartylglutamate (NAAG) peptidase inhibitor; structure in first source | ||
psma-617 | PSMA-617: inhibits prostate-specific membrane antigen; structure in first source |